ID   K7N5M3_HUMAN            Unreviewed;       220 AA.
AC   K7N5M3;
DT   09-JAN-2013, integrated into UniProtKB/TrEMBL.
DT   09-JAN-2013, sequence version 1.
DT   28-JAN-2026, entry version 72.
DE   SubName: Full=Human nkt tcr alpha chain {ECO:0000313|PDB:4EN3};
DE   SubName: Full=Human nkt tcr beta chain {ECO:0000313|PDB:4EN3};
GN   Name=B2M {ECO:0000313|PDB:4EN3};
GN   ORFNames=HDCMA22P {ECO:0000313|PDB:4EN3};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|PDB:4EN3};
RN   [1] {ECO:0000313|PDB:4EN3, ECO:0007829|PDB:4EN3}
RP   X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) IN COMPLEX WITH
RP   N-ACETYL-D-GLUCOSAMINE, AND DISULFIDE BONDS.
RX   PubMed=23109910; DOI=10.1371/journal.pbio.1001412;
RA   Lopez-Sagaseta J., Kung J.E., Savage P.B., Gumperz J., Adams E.J.;
RT   "The molecular basis for recognition of CD1d/alpha-galactosylceramide by a
RT   human non-Valpha24 T cell receptor.";
RL   PLoS Biol. 10:e1001412-e1001412(2012).
RN   [2] {ECO:0007829|PDB:4NDM}
RP   X-RAY CRYSTALLOGRAPHY (3.01 ANGSTROMS) OF 118-220, AND DISULFIDE BONDS.
RX   PubMed=24239091; DOI=10.1016/j.immuni.2013.11.001;
RA   Luoma A.M., Castro C.D., Mayassi T., Bembinster L.A., Bai L., Picard D.,
RA   Anderson B., Scharf L., Kung J.E., Sibener L.V., Savage P.B., Jabri B.,
RA   Bendelac A., Adams E.J.;
RT   "Crystal structure of Vdelta1 T cell receptor in complex with CD1d-
RT   sulfatide shows MHC-like recognition of a self-lipid by human gammadelta T
RT   cells.";
RL   Immunity 39:1032-1042(2013).
RN   [3] {ECO:0007829|PDB:4MJI}
RP   X-RAY CRYSTALLOGRAPHY (2.99 ANGSTROMS) OF 7-203, AND DISULFIDE BONDS.
RX   PubMed=24600035; DOI=10.4049/jimmunol.1302667;
RA   Motozono C., Kuse N., Sun X., Rizkallah P.J., Fuller A., Oka S., Cole D.K.,
RA   Sewell A.K., Takiguchi M.;
RT   "Molecular basis of a dominant T cell response to an HIV reverse
RT   transcriptase 8-mer epitope presented by the protective allele HLA-
RT   B*51:01.";
RL   J. Immunol. 192:3428-3434(2014).
RN   [4] {ECO:0007829|PDB:4ZAK}
RP   X-RAY CRYSTALLOGRAPHY (2.82 ANGSTROMS) OF 109-210, AND DISULFIDE BONDS.
RX   PubMed=26078271; DOI=10.4049/jimmunol.1500070;
RA   Birkholz A.M., Girardi E., Wingender G., Khurana A., Wang J., Zhao M.,
RA   Zahner S., Illarionov P.A., Wen X., Li M., Yuan W., Porcelli S.A.,
RA   Besra G.S., Zajonc D.M., Kronenberg M.;
RT   "A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-
RT   gamma Production.";
RL   J. Immunol. 195:924-933(2015).
RN   [5] {ECO:0007829|PDB:5E6I}
RP   X-RAY CRYSTALLOGRAPHY (4.00 ANGSTROMS) OF 3-210, AND DISULFIDE BONDS.
RA   Gao M.;
RT   "Crystal structure of TCR PF8 in complex with flu MP(58-66) epitope
RT   presented by HLA-A2.";
RL   Submitted (OCT-2015) to the PDB data bank.
RN   [6] {ECO:0007829|PDB:5WLG}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 9-9 AND 118-194, AND DISULFIDE
RP   BONDS.
RX   PubMed=29150238; DOI=10.1016/j.immuni.2017.10.013;
RA   Van Braeckel-Budimir N., Gras S., Ladell K., Josephs T.M., Pewe L.,
RA   Urban S.L., Miners K.L., Farenc C., Price D.A., Rossjohn J., Harty J.T.;
RT   "A T Cell Receptor Locus Harbors a Malaria-Specific Immune Response Gene.";
RL   Immunity 47:835-847.e4(2017).
RN   [7] {ECO:0007829|PDB:5MEN}
RP   X-RAY CRYSTALLOGRAPHY (2.81 ANGSTROMS) OF 124-206, AND DISULFIDE BONDS.
RX   PubMed=27903649; DOI=10.1074/jbc.m116.741603;
RA   Cole D.K., van den Berg H.A., Lloyd A., Crowther M.D., Beck K.,
RA   Ekeruche-Makinde J., Miles J.J., Bulek A.M., Dolton G., Schauenburg A.J.,
RA   Wall A., Fuller A., Clement M., Laugel B., Rizkallah P.J., Wooldridge L.,
RA   Sewell A.K.;
RT   "Structural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone
RT   That Recognizes a Peptide Derived from Human Telomerase Reverse
RT   Transcriptase.";
RL   J. Biol. Chem. 292:802-813(2017).
RN   [8] {ECO:0007829|PDB:6MIV, ECO:0007829|PDB:6MIY}
RP   X-RAY CRYSTALLOGRAPHY (1.93 ANGSTROMS) OF 3-3; 96-114 AND 116-210, AND
RP   DISULFIDE BONDS.
RX   PubMed=30556652; DOI=10.1002/cmdc.201800649;
RA   Janssens J., Bitra A., Wang J., Decruy T., Venken K., van der Eycken J.,
RA   Elewaut D., Zajonc D.M., van Calenbergh S.;
RT   "4"-O-Alkylated alpha-Galactosylceramide Analogues as iNKT-Cell Antigens:
RT   Synthetic, Biological, and Structural Studies.";
RL   ChemMedChem 14:147-168(2019).
RN   [9] {ECO:0007829|PDB:6CW6}
RP   X-RAY CRYSTALLOGRAPHY (2.85 ANGSTROMS) OF 3-210, AND DISULFIDE BONDS.
RX   PubMed=31391251; DOI=10.1074/jbc.ra119.009963;
RA   Wang J., Guillaume J., Janssens J., Remesh S.G., Ying G., Bitra A.,
RA   Van Calenbergh S., Zajonc D.M.;
RT   "A molecular switch in mouse CD1d modulates natural killer T cell
RT   activation by alpha-galactosylsphingamides.";
RL   J. Biol. Chem. 294:14345-14356(2019).
RN   [10] {ECO:0007829|PDB:6D78}
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 5-206, AND DISULFIDE BONDS.
RX   PubMed=30617019; DOI=10.1016/j.ymthe.2018.12.010;
RA   Hellman L.M., Foley K.C., Singh N.K., Alonso J.A., Riley T.P., Devlin J.R.,
RA   Ayres C.M., Keller G.L.J., Zhang Y., Vander Kooi C.W., Nishimura M.I.,
RA   Baker B.M.;
RT   "Improving T Cell Receptor On-Target Specificity via Structure-Guided
RT   Design.";
RL   Mol. Ther. 27:300-313(2019).
RN   [11] {ECO:0007829|PDB:5VCJ}
RP   X-RAY CRYSTALLOGRAPHY (3.16 ANGSTROMS) OF 3-3 AND 116-210, AND DISULFIDE
RP   BONDS.
RX   PubMed=30656346; DOI=10.1039/c8ob02982b;
RA   Compton B.J., Farrand K.J., Tang C.W., Osmond T.L., Speir M.,
RA   Authier-Hall A., Wang J., Ferguson P.M., Chan S.T.S., Anderson R.J.,
RA   Cooney T.R., Hayman C.M., Williams G.M., Brimble M.A., Brooks C.R.,
RA   Yong L.K., Metelitsa L.S., Zajonc D.M., Godfrey D.I., Gasser O.,
RA   Weinkove R., Painter G.F., Hermans I.F.;
RT   "Enhancing T cell responses and tumour immunity by vaccination with
RT   peptides conjugated to a weak NKT cell agonist.";
RL   Org. Biomol. Chem. 17:1225-1237(2019).
RN   [12] {ECO:0007829|PDB:6R2L}
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 3-3 AND 118-198, AND DISULFIDE
RP   BONDS.
RX   PubMed=32310221; DOI=10.1172/jci130562;
RA   Holland C.J., Crean R.M., Pentier J.M., de Wet B., Lloyd A.,
RA   Srikannathasan V., Lissin N., Lloyd K.A., Blicher T.H., Conroy P.J.,
RA   Hock M., Pengelly R.J., Spinner T.E., Cameron B., Potter E.A.,
RA   Jeyanthan A., Molloy P.E., Sami M., Aleksic M., Liddy N., Robinson R.A.,
RA   Harper S., Lepore M., Pudney C.R., van der Kamp M.W., Rizkallah P.J.,
RA   Jakobsen B.K., Vuidepot A., Cole D.K.;
RT   "Specificity of bispecific T cell receptors and antibodies targeting
RT   peptide-HLA.";
RL   J. Clin. Invest. 130:2673-2688(2020).
RN   [13] {ECO:0007829|PDB:6V80}
RP   X-RAY CRYSTALLOGRAPHY (3.53 ANGSTROMS) OF 96-210, AND DISULFIDE BONDS.
RX   DOI=10.1038/s43018-020-00111-6;
RA   Shahine A., Rossjohn J.;
RT   "A single-domain bispecific antibody targeting CD1d and the NKT T-cell
RT   receptor induces a potent antitumor response.";
RL   Nat. Cancer 1:1054-1065(2020).
RN   [14] {ECO:0007829|PDB:6PX6}
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 3-210, AND DISULFIDE BONDS.
RX   PubMed=31974305; DOI=10.1073/pnas.1914308117;
RA   Ting Y.T., Dahal-Koirala S., Kim H.S.K., Qiao S.W., Neumann R.S.,
RA   Lundin K.E.A., Petersen J., Reid H.H., Sollid L.M., Rossjohn J.;
RT   "A molecular basis for the T cell response in HLA-DQ2.2 mediated celiac
RT   disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 117:3063-3073(2020).
RN   [15] {ECO:0007829|PDB:8T4Z}
RP   X-RAY CRYSTALLOGRAPHY (2.69 ANGSTROMS) OF 116-210, AND DISULFIDE BONDS.
RX   PubMed=39141352; DOI=10.1073/pnas.2321686121;
RA   Cheng T.Y., Praveena T., Govindarajan S., Almeida C.F., Pellicci D.G.,
RA   Arkins W.C., Van Rhijn I., Venken K., Elewaut D., Godfrey D.I.,
RA   Rossjohn J., Moody D.B.;
RT   "Lipidomic scanning of self-lipids identifies headless antigens for natural
RT   killer T cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 121:e2321686121-e2321686121(2024).
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000256|ARBA:ARBA00004236}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   PDB; 4EN3; X-ray; 2.57 A; A=1-220.
DR   PDB; 4MJI; X-ray; 2.99 A; D/I=7-203.
DR   PDB; 4NDM; X-ray; 3.01 A; B=118-220.
DR   PDB; 4ZAK; X-ray; 2.82 A; C=3-3, C=117-210.
DR   PDB; 5E6I; X-ray; 4.00 A; A/F/G/P=3-210.
DR   PDB; 5MEN; X-ray; 2.81 A; D=124-206.
DR   PDB; 5VCJ; X-ray; 3.16 A; C=3-3, C=116-210.
DR   PDB; 5WLG; X-ray; 2.10 A; D/I=9-94, D/I=118-194.
DR   PDB; 6CW6; X-ray; 2.85 A; C=3-210.
DR   PDB; 6D78; X-ray; 2.35 A; D=5-206.
DR   PDB; 6MIV; X-ray; 2.05 A; C=3-3, C=96-114, C=116-210.
DR   PDB; 6MIY; X-ray; 2.75 A; C/G=3-3, C/G=96-114, C/G=116-210.
DR   PDB; 6MJ4; X-ray; 2.00 A; C=3-3, C=96-114, C=116-210.
DR   PDB; 6MJ6; X-ray; 2.45 A; C=3-3, C=96-114, C=116-210.
DR   PDB; 6MJA; X-ray; 2.35 A; C=3-3, C=96-114, C=116-210.
DR   PDB; 6MJI; X-ray; 2.30 A; C=3-3, C=96-114, C=116-210.
DR   PDB; 6MJJ; X-ray; 1.93 A; C=3-3, C=96-114, C=116-210.
DR   PDB; 6MJQ; X-ray; 3.00 A; C/G=3-3, C/G=96-114, C/G=116-210.
DR   PDB; 6PX6; X-ray; 3.00 A; D=3-210.
DR   PDB; 6R2L; X-ray; 2.30 A; D=3-3, D=118-198.
DR   PDB; 6V80; X-ray; 3.53 A; C/H=96-210.
DR   PDB; 8T4Z; X-ray; 2.69 A; C=116-210.
DR   PDBsum; 4EN3; -.
DR   PDBsum; 4MJI; -.
DR   PDBsum; 4NDM; -.
DR   PDBsum; 4ZAK; -.
DR   PDBsum; 6MIV; -.
DR   PDBsum; 6MIY; -.
DR   PDBsum; 6MJ4; -.
DR   PDBsum; 6MJ6; -.
DR   PDBsum; 6MJA; -.
DR   PDBsum; 6MJI; -.
DR   PDBsum; 6MJJ; -.
DR   PDBsum; 6MJQ; -.
DR   PDBsum; 6PX6; -.
DR   PDBsum; 6R2L; -.
DR   AlphaFoldDB; K7N5M3; -.
DR   SMR; K7N5M3; -.
DR   PeptideAtlas; K7N5M3; -.
DR   OrthoDB; 9949628at2759; -.
DR   ChiTaRS; B2M; human.
DR   EvolutionaryTrace; K7N5M3; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   CDD; cd07688; IgC_TCR_alpha; 1.
DR   CDD; cd04983; IgV_TCR_alpha; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   InterPro; IPR015370; TCR_alpha_C.
DR   InterPro; IPR052051; TCR_complex_component.
DR   PANTHER; PTHR19433:SF85; T CELL RECEPTOR ALPHA VARIABLE 17-RELATED; 1.
DR   PANTHER; PTHR19433; T-CELL RECEPTOR ALPHA CHAIN V REGION-RELATED; 1.
DR   Pfam; PF09291; DUF1968; 1.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 2.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure {ECO:0007829|PDB:4EN3, ECO:0007829|PDB:4MJI};
KW   Adaptive immunity {ECO:0000256|ARBA:ARBA00023130};
KW   Cell membrane {ECO:0000256|ARBA:ARBA00022475};
KW   Disulfide bond {ECO:0000256|ARBA:ARBA00023157};
KW   Glycoprotein {ECO:0000256|ARBA:ARBA00023180};
KW   Immunity {ECO:0000256|ARBA:ARBA00022859};
KW   Membrane {ECO:0000256|ARBA:ARBA00023136};
KW   Signal {ECO:0000256|ARBA:ARBA00022729}.
FT   DOMAIN          1..92
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DISULFID        26..92
FT                   /evidence="ECO:0007829|PDB:4EN3, ECO:0007829|PDB:4MJI"
FT   DISULFID        139..189
FT                   /evidence="ECO:0007829|PDB:4EN3, ECO:0007829|PDB:4MJI"
SQ   SEQUENCE   220 AA;  24492 MW;  C8D59B9563ACA1FB CRC64;
     ADLSQQGEED PQALSIQEGE NATMNCSYKT SINNLQWYRQ NSGRGLVHLI LIRSNEREKH
     SGRLRVTLDT SKKSSSLLIT ASRAADTASY FCATYDRGST LGRLYFGRGT QLTVWPDIQN
     PDPAVYQLRD SKSSDKSVCL FTDFDSQTNV SQSKDSDVYI TDKCVLDMRS MDFKSNSAVA
     WSNKSDFACA NAFNNSIIPE DTFFPSPESS SRGGLEVLFQ
//
